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Painful diabetic neuropathy (PDN) is a common complication 
of diabetes. This study explored the experience and impact of 
living with PDN.
Design
People with PDN were recruited through local NHS clinics 
and by national advertisement in diabetes support publications 
and social media forums. Semi-structured interviews were 
conducted either in person or by telephone. Data were 
analysed using inductive thematic analysis.
Results
Twenty-three people (12 female, 13 with Type-2 diabetes; 
22 identified as White British) were interviewed who had 
PDN symptoms for mean 10 years (range 1-24 years). Four 
superordinate themes were identified from the data: The 
experience of living with PDN, Affects those around me, A 
range of negative emotions and Life is a constant challenge.
Conclusions
People with PDN experience a wider range of impacts than 
those previously reported in research literature, for example: 
embarrassment, anger, altered diet, reduced intimacy 
and social isolation. Whilst further research is warranted 
with a diverse ethnic sample the findings indicate that the 
wide-ranging impact of PDN on quality of life needs to be 
recognised in clinical practice and incorporated into future 
research.
Contribution of the paper
• The majority of research into painful diabetic neuropathy 
uses validated outcome measures, there are very few 
qualitative studies investigating the impact of PDN.
• This paper highlights there are more and varied impacts of 
PDN, than captured by the existing research
Key words – diabetes, neuropathy, chronic pain, quality of 
life, qualitative research
Introduction
Diabetic peripheral neuropathy, leading to sensory loss, 
affects up to 50% of people [1,2]. Data suggest around 20% 
of people with diabetes experience sensory loss and pain, 
termed painful diabetic neuropathy (PDN) [2]. This presents 
as burning pain in a ‘glove and stocking’ distribution that is 
usually constant, daily and with moderate to severe intensity 
[3]. PDN is associated with a significant impact on physical 
and mental health and reduced quality of life, over and above 
the impact of diabetes alone [4,5].
Most research into the impact of PDN pain has been conducted 
using validated self-report questionnaires. Quality of life 
and functional state have been measured using the generic 
EQ5D [6,7], Brief Pain Inventory (BPI) [3,8] and SF36 
questionnaires [9]. One limitation of questionnaire-based 
research is the preset range of questions and responses, which 
may not encompass all the factors experienced as a result of 
the health condition [10]. This is particularly the case where 
patient groups have not been involved in the development of 
core outcome measures [11]. A specific example of this is in 
rheumatoid arthritis where fatigue was identified by patients 
as missing from the core set of outcomes [12]. Development 
of a specific outcome measure and subsequent research 
findings have ensured that fatigue management strategies are 
now recommended as a key component of management for 
people with rheumatoid arthritis [13].
Current treatment recommendations for neuropathic pain [14] 
are entirely pharmacological, but the medications are often 
ineffective and/or have unwanted side effects [15]. Persistent 
pain of all causes is known to affect multiple quality of life 
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dimensions and cohort studies have demonstrated differences 
in symptom profile between neuropathic and nociceptive 
pain conditions [16]. Persistent pain conditions should not be 
considered homogenous [17]; the National Institute for Health 
and Care Excellence (NICE, UK) has recommended research 
into the factors which affect participation in life and quality of 
life, specifically in people with neuropathic pain [14].
In PDN there are few qualitative studies; Brod et al. present 
data from interviews and focus groups which highlight four 
domains where PDN impacts on quality of life: physical 
function, daily life, social/psychological functioning and 
sleep but this study was carried out in the USA and may not 
be of direct relevance to the UK population with different 
sociodemographic profiles and healthcare systems [18]. 
Kanera et al. explored specifically how physical activity levels 
were affected by fears related to PDN, pain and balance using 
a focus group [19].
The aim of this study was to explore the experiences of people 
living with PDN, and the impact it had on their lives.
Method
We carried out semi-structured interviews with people who 
self-reported a diagnosis of PDN, in order to understand the 
impacts PDN had on their lives.
Participant recruitment
Recruitment was 1) through local NHS diabetes and 
PDN-specialist clinics, where clinicians independent of the 
research provided brief study information to eligible patients; 
and 2) by advertisement in Balance, the peer-support magazine 
of DiabetesUK, a leading UK-based diabetes support charity. 
Individuals who contacted the research team and met 
eligibility criteria were sent detailed study information and 
given the opportunity to ask questions about the study. If, 
having received this information and had questions answered, 
they consented to be interviewed, an appropriate date for 
interview was scheduled. 
Eligibility criteria
Participants were required to self-report painful neuropathy 
secondary to diabetes and be able to communicate in 
conversational English. There were no other exclusion 
criteria; this aimed for the widest range of PDN experience 
to be reflected by the study participants.
Interview process
If respondents met the criteria, and gave consent, one-to-one 
interviews were scheduled. These were conducted, either on 
University premises, at the person’s home or by telephone 
according to individual preference. The interviews were 
semi-structured based on an interview schedule which 
had been developed by the research team and an Expert 
Patient Research Partner (EPRP). The schedule (online S1) 
was grounded in the existing literature, the study research 
questions, and the experience of the research team. The 
schedule was used to ensure all topics were covered during the 
interview. All interviews were conducted by the PhD research 
student (BD), a physiotherapist, who has extensive clinical 
experience of managing persistent musculoskeletal pain. The 
clinical profession of the interviewer was made clear in the 
study information and when the interviews were scheduled, 
but was not referred to again through the interview unless 
by the participant. No clinical advice was offered during the 
interview.
The interviews were digitally recorded and transcribed verbatim 
by professional transcription services. Contemporaneous field 
notes were taken to allow contextualization and reflection on 
the interview through the analysis phase.
Data analysis
The transcribed text was imported to NVivo (NVivo version 
11 for Mac, QSR International) for management and analysed 
using an inductive thematic analysis approach [20]. The 
researcher examined the transcripts and assigned a ‘code’ to 
each substantive element mentioned by participants. These 
initial ‘codes’ were designed to represent the participant’s 
point as closely as possible and were created with reference 
to that interview alone, irrespective of the other transcripts. 
This analysis made no assumptions about the experiences 
of interview participants. These codes were grouped into 
organising themes containing a central concept. Themes 
were then further brought together as superordinate themes 
where appropriate. The data coding and theme development 
was done by BD with supervision and support from a senior 
member of the research team (CM). CM has extensive 




All except one individual who contacted the researcher 
were interviewed. The person excluded had neuropathy but 
no pain. Twenty-three participants were recruited with a 
mean age of 62 years (range 24-86 years); 12 were women. 
All except one participant identified themselves as White 
British. Ten participants had Type 1 diabetes. Participants 
self-reported being diagnosed with diabetes for a mean of 23 
years (range 7-50 years) and having experienced PDN for a 
mean of 10 years (range 1-24 years). A summary of participant 
characteristics is presented in Table 1. The interviews lasted 
between 30 and 120 minutes.
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Table 1 – participant characteristics

















Duration with Diabetes (years) 23.5 (7-50)








The participants described a wide variety of impacts due to 
PDN. For the majority of participants, most facets of everyday 
life were affected in some way. The codes were grouped into 
four main themes: those describing the subjective experience 
of PDN (The personal experience of living with PDN); the 
impact PDN had on the participant’s wider social network 
(Affects those around me); the impact on mood state (A 
range of negative emotions); and lastly, the day-to-day impact 
of PDN (Life is a constant challenge). These four themes are 
outlined in Table 2, and in more detail in the next sections. 
Anonymous quotes are presented using pseudonyms with the 
participant’s gender (M/F) and age.
Theme - The personal experience of living 
with PDN
Participants spoke about the challenge of living with PDN from 
two perspectives. They described the personal experience of 
PDN in sub-theme: A sensory experience.
Table 2 – code structure of themes
Superordinate 
theme
The impact of PDN




A range of negative 
emotions


















A very personal problem
What other people think
A hidden problem no-one 
else sees
Considering others
Keeping it to myself
Making the most of life









Worries for the future
Emotional anger
Suicide






No quality of life
Pain makes me mean
Increasingly on my own
Becoming socially isolated
Struggling with social life
Not going out
Be on my own
A shrinking world
Losing mobility










Harder to remain at work
Affecting concentration
Not able to do my work





Day to day life is a struggle
Affecting day to day activity
Can’t sit for too long
PDN difficult to cope with
Affecting all aspects of life




Morning pain not been moving
Problem with footwear
Regular foot checks
Advice for foot care
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Sub-theme - A sensory experience
There were evocative descriptions of experiencing PDN, such 
as “like Templar Torture”, from when Templar Knights had boiling 
oil poured over their feet to extract confessions. Participants 
described the contradiction between numb feet where there 
was no pain experienced from tissue damage versus a burning 
pain sensation serving no purpose.
“…you get that numbness and then on the other hand the extreme 
pain.” Bob, M63.
There was a similar contradiction for patients whereby their 
feet looked normal despite the perceived pain.
“You know what I mean, they’re not gnarled and knotty, they look 
quite ordinary feet and yet they’ve got this most incredible pains.” 
Lisa, F69.
Sub-theme - A very personal problem
A second sub-theme described how people felt viewed by 
others and how their sense of self or identity had changed 
due to PDN. Participants described feeling that other 
people had negative perceptions of them because there was 
nothing to ‘see’ to explain the pain. A lack of validation led to 
participants not talking about the problem, instead, they kept 
their experience to themselves.
“I would say “oh, no it’s been an ok day” when actually it’s been an 
awful day.” Mary, F44.
A counterview was captured in the sub-theme: Making the 
most of life. There were participants for whom PDN caused 
minimal interruption to their lives and did not greatly affect 
their quality of life. In order to cope positively, and make the 
most of life, some participants viewed PDN as a challenge to 
conquer. This required optimism and setting daily goals.
“What you don’t do is waste it [energy], just feeling sorry for yourself, 
I’m in pain again, that’s no good. You’ve got to feed that emotion into 
something else.” Anne, F52.
Theme - Affects those around me
Participants described how PDN impacted people close to 
them and affected their relationships with partners and family.
“... back to, to the eighties and early nineties, it [PDN] caused a, it 
caused the divorce between me and my wife – she couldn’t handle it 
anymore – and we had a divorce.” Mark, M62.
It affected their communication and made them less tolerant 
of family and friends around them.
“… the pain takes over, um, and you might, sort of, turn around 
and you’ve spoken sharply [...] because sometimes [name] will say 
afterwards, ‘you don’t need to say it quite like that’.” Ellen, F63
Participants demonstrated this reduced tolerance by being 
more easily irritated in conversation or by other peoples’ 
actions. They actively removed themselves from their social 
environment, choosing instead to be on their own.
“I think there’s just really, if my wife comes and talks to me, I say to 
her, ‘look, I’m sorry I can’t, I can’t answer you, I don’t want to talk to 
you.’” Aaron, M75.
Theme - A range of negative emotions
Participants gave clear examples of negative emotions such as 
feeling angry with themselves or their feet.
“you know I do get bad tempered and I think ‘why bloody me?’ you 
know. You hate your feet in a way.” Philip, M57.
Two participants indicated that they had attempted suicide 
because of the pain,
“…but I just get too down and I have tried to take my own life three 
or four times. Well I suppose by trying to take overdoses and things, I’m 
not coping with it [PDN].” Kate, F58.
They were embarrassed because of social restrictions and 
depressed because of the on-going problems they had to cope 
with.
“I had to go out in the garden and I had to make out that I felt sick 
because I was too embarrassed to say about these pains in my leg 
because there was nothing there, there was nothing to show and our 
son came and picked us up and we went home.” Joan, F57.
There were clear examples of worry about specific issues such 
as money and health, as well as general concern about the 
future, the unknown and how their pain and disability might 
progress in the future.
“And the biggest [issue] probably, anxious problems about the future.” 
Daniel, M67.
Participants described frustration from difficulty or inability 
to complete simple tasks due to symptoms they experienced 
and this frustration links to the next theme.
Theme - Life is a constant challenge.
This was a large theme that contained five sub-themes: 
Increasingly on my own, A shrinking world, Sleep and fatigue, 
Harder to remain at work and Day to day life is a struggle.
Sub-theme - Increasingly on my own
Participants described social isolation due to cancelling 
arrangements or limiting their social life
“It makes you a hermit …” Bob, M63.
Some participants had lost confidence to go out by themselves.
“It’s like I say we have got no social life whatsoever because I never 
know from one day to the next whether I am going to be alright to go 
out or not, it becomes embarrassing and I would rather just stay in.” 
Joan, F57.
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Sub-theme - A shrinking world
Participants described their lives being confined by PDN, due 
to reduced physical and specifically, walking capacity.
“… unfortunately the pain got greater and greater to where I couldn’t 
walk. It gave you the impression that you’re walking on broken glass.” 
Philip, M57.
As well as reduced walking, participants struggled using foot 
pedals when driving and hence lost confidence.
“It’s the same with driving, if you go on a long journey you’d be 
in that car and some days your feet would burn that much just by 
keeping it on the throttle.” Philip, M57.
The combination of these restrictions led to loss of 
independence, and a sense that life had become increasingly 
narrow.
“You feel to be, sort of entering this funnel where the choice is, life 
choices are getting smaller and smaller because of the restrictions, you 
know, um, you’ll learn what not to do.” Jane, F68.
Sub-theme - Sleep and Fatigue
Most participants described difficulty initiating sleep and, or, 
remaining asleep.
“It tends to just appear at night-time when I’m lying down, which 
means that it disturbs my sleep, which is the biggest impact of the lot.” 
Sam, M53
A common complaint was the weight of bedclothes on their 
feet. There were descriptions of how uncomfortable the 
lightest sheet could be.
“Even in bed at night, the sheet is too heavy on my feet. You feel as if 
you’d like a cradle.” Ellen, F63.
They also described the consequences of poor sleep, 
particularly with maintaining concentration and ability for 
everyday activity and function.
“It’s really, really bad and I’m just tired all the time, exhausted, I’ve 
totally forgotten about tiredness.” Anne, F52
However, there were some participants who did not 
experience night pain or sleep disturbance due to PDN.
“I have no problem with sleep, no.” Mike, M65.
Sub-theme - Harder to remain at work
Although most participants were retired, some were working 
and this had become challenging due to pain levels, pain 
interfering with concentration, and fatigue from frequently 
disturbed sleep. Participants found their work role was 
important in providing and maintaining a sense of self.
As a counter point, there were employed participants who 
did not find PDN affected their ability to perform their role.
“I’ve never, pretty much ninety-nine per cent of the time, never suffered 
with it when I’ve been at work or volunteering…” Sam, M53.
Sub-theme - Day to day life is a struggle
This sub-theme was constructed from descriptions about 
unique impacts of PDN which were separate and distinct from 
impacts outlined in previous sub-themes. This demonstrates 
the breadth of impact PDN had on everyday activity. The 
impacts include the physical difficulty of getting up from bed 
in the morning and the difficulty experienced in simply sitting 
still - people were unable to sit through a film or dinner with 
friends, without needing to get up and move. Participants 
found PDN could make them feel nauseous which affected 
their appetite for food and consequent diabetes management. 
Participants disclosed their intimate relationships with 
partners had diminished or ceased because of PDN. Because 
of sensory loss, participants were aware of the need for foot 
care and surveillance and, closely allied to this, some had 
problems buying appropriate fitting footwear. Participants 
reflected how life had altered since they developed symptoms 
of PDN; they particularly focused on lost independence and 
how their personality may have changed. Lastly, participants 
spoke generally about the restrictions to daily activity, the 
implication being that all aspects of life were affected by PDN.
“You try and get across what this pain does to you, it’s a depravity, is 
that the word?” Anne, F52.
“I’ve had to have treatment for my eyes, for retinopathy and things like 
that, kidneys are okay, but it’s, I guess it’s the neuropathy that is so 
intrusive and painful at times.” Dawn, F68.
Discussion
Previous research has highlighted that PDN is painful; makes 
walking, standing and general activity more difficult and 
affects sleep and mood adversely. Previous studies mainly 
used questionnaires to gather data and these questionnaires 
have a restricted range of questions and responses.
The findings from the current study add personal insight to 
the experience of living with PDN. The results are broadly 
in line with results from previous mixed focus group and 
interviews from the USA [18]. The findings from Brod et al 
[18] identified four domains by which PDN impacted on the 
lives of their participants and it is encouraging that the range 
of impacts in the current study are similar irrespective of the 
population differences and health care systems experienced 
by USA and UK participants. This suggests some universality 
of the experience of PDN, but caution must be taken not to 
necessarily extrapolate these findings, to other populations.
Additional aspects to the PDN experience not previously 
reported were identified in the current study including: 
restless leg-type symptoms, headaches, muscle cramps, and 
breathlessness. It is however unknown how common these 
symptoms maybe in this population.
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Participants experienced pain for which others could see no 
obvious cause, this created a feeling of invalidation for their 
experience, a finding that has been described in other persistent 
pain conditions. For example, in people with neuropathic pain 
a lack of understanding from other people, about the severity 
of their pain and the associated disability, had a negative effect 
on their personal relationships [21]. Similarly, non-specific 
low back pain is commonly experienced, yet not often 
associated with clear causative structural factors based on 
medical imaging investigations [22], this diagnostic ambiguity 
has led people to feel stigmatized by others [23–25].
Experiencing emotions such as depression and anxiety 
are common in persistent pain conditions [26] and in the 
population with diabetes [27]. A large cohort study using 
the Hospital Anxiety and Depression Scale in people with 
diabetes found 32% of respondents had mild to severe anxiety 
and 22% had mild to severe depression [27]. The presence 
of two or more diabetes-related complications, such as PDN, 
was associated with an odds-ratio of 2.75 for the presence 
of anxiety and 3.99 for the presence of depression. People 
with PDN co-exist in both these population groups and it 
is not surprising that the current data shows themes related 
to depression and anxiety, but there were also additional 
emotional issues such as: embarrassment, anger, frustration, 
loss of autonomy and suicidal thoughts.
Sense of embarrassment can link back to altered self-image, 
if ones functional ability is less than it ‘should be’. 
Embarrassment has been studied in osteoarthritis, where 
qualitative research found participants described balancing 
the risk of pain versus embarrassment, when considering 
physical activity [28]. Osteoarthritis tends to be characterised 
by increasing pain with increasing activity [29], more so than 
in neuropathic pain conditions, when pain can be much more 
spontaneous and unpredictable [3]. The spontaneous nature of 
PDN pain was a factor in a previous focus group study [19], 
and led to increased fatigue, fear of falling, loss of identity and 
worsening self-evaluation. These last two issues link back to 
the sense of emotional frustration identified by participants in 
the current study.
Lastly, the increased sense of social isolation was captured in 
the theme Increasingly on my own. Social isolation and lack 
of social support has been associated with worsening diabetes 
control measured by HbA1c, blood pressure control and lipid 
levels [30]. The key driver for development of microvascular 
complications such as PDN is poor glycaemic control [31]. 
Similarly, persistent pain has been found more frequently in 
older adults who identify as lonely (odds ratio 1.23) [32], and 
social isolation is predictive of disability related to low back 
pain at 6-month follow up (β=-0.91) [33].
A full discussion of the concepts of social isolation, social 
support and loneliness are beyond the scope of this paper, 
but it is clear these issues do not improve diabetes control, 
pain-related disability or quality of life [34]. Aiming to help 
people reduce social isolation and build social networks is 
supported by research but can often be difficult to action in 
clinical practice [35].
Limitations
The primary limitation of this study was the lack of 
sociodemographic diversity in the sample population. All 
except one participant identified as White British. The age and 
duration of diabetes and PDN are transferable, but different 
genetic profiles and ethnic backgrounds have differing 
prevalence rates for diabetes [36]. Different social groups and 
religious affiliations also have tendencies toward different pain 
coping strategies [37].
Future research
Pharmacological management approaches alone are not fully 
successful in managing PDN. The breadth of impact identified 
in this study suggests multi-faceted and multidisciplinary 
approaches as used in pain management programmes may be 
required. However, neuropathic pain has a different clinical 
profile than musculoskeletal pain, and people with PDN have 
underlying diabetes and possibly other related co-morbidities, 
as well as pain, and strategies may require revision to be 
acceptable and appropriate to this group of people. To 
explore whether these impacts were more commonplace in 
the population with PDN, the current findings were used 
to inform an internet survey to quantify the frequency with 
which these impacts were experienced and explore which of 
these impacts would be a priority for treatment interventions 
[38].
Conclusions
Our study has shown PDN has wide-ranging impacts on 
quality of life, beyond those identified in previous research. 
There were a range of subjective experiences identified 
beyond pain alone, including a broad range of emotional 
responses including anger, embarrassment and frustration, 
and a strong theme of social isolation. It is as yet unknown 
how frequent these impacts are in the wider population with 
PDN or how they should be measured and managed clinically 
to optimise quality of life for people with PDN.
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Please tell me 
about your life 
with PDN?
• Tell me more about how it affects 
your working day?
• Can you elaborate on how it affects 
your social life?
• Are there ways in which this affects 
your relationships
• In what ways do others close to 
you support you in managing this 
problem?
